Security key
207523101
Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (CNTB)
CUSIP: 207523101
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / Ordinary shares, par value $0.000174
- Shares outstanding
- 62,516,710
- Total 13F shares
- 1,247
- Share change
- -41
- Total reported value
- $3,267
- Reported price per share
- $2.62
- Number of holders
- 1
- Value change
- -$107
- Number of sells
- 1
Security identity
Holder snapshot
Report period
Q1 2026
Institutions
1
Top holders
1
CNTB full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Connect Biopharma Holdings Ltd SEC filings
Connect Biopharma Holdings Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP 207523101
Recent filing periods:
Ownership snapshot
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary shares, par value $0.000174 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Panacea Innovation Ltd
13D/G signal
Panacea Innovation Ltd
Evidence rows
38
Latest as of
31 Mar 2026
13D/G
13F
3/4/5
Lead comparable stake: 21%
13D/G row: Panacea Innovation Ltd
Showing 1-8 of 38 holder rows.
Rank 1 holder
Panacea Innovation Ltd
13D/G
- Ownership
- 21%
- Position
- $36.85M
Rank 2 holder
Ikarian Capital, LLC
13D/G
13F
- Ownership
- 8.8%
- Position
- $13.91M
Rank 3 holder
Wei Zheng
13D/G
- Ownership
- 6.2%
- Position
- $145.35M
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Panacea Innovation Ltd |
13D/G
Panacea Innovation Limited
|
21%
|
$36,848,000
13,160,000 shares
|
+$3,248,000 | 31 Mar 2026 |
| Ikarian Capital, LLC |
13D/G
13F
Company
|
8.8%
|
$13,910,809
4,933,086 shares
|
$0 | 31 Dec 2025 |
| Wei Zheng |
13D/G
|
6.2%
|
$145,351,350
3,876,036 shares
|
-$42,747,150 | 31 Mar 2026 |
| James Huang |
3/4/5
Director
|
21%
|
$45,402,000
13,160,000 shares
|
+$4,002,000 | 31 Mar 2026 |
| Barry D. Quart |
3/4/5
Chief Executive Officer, Director
|
0.36%
|
$593,689
224,034 shares
|
— | 16 Mar 2026 |
| David Leslie Szekeres |
3/4/5
President
|
0.35%
|
$571,708
215,739 shares
|
— | 16 Mar 2026 |
| Kleanthis Gabriel Xanthopoulos |
3/4/5
Director
|
0.13%
|
$233,541
82,816 shares
|
— | 31 Mar 2026 |
| Lisa Peraza |
3/4/5
Senior Vice President, Finance
|
0.07%
|
$119,750
45,189 shares
|
— | 16 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
1,247
Rows available
1
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
1
Q1 2026 holders
1
Holder diff
0
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend